LifeHealthcare will sell STIMULAN and genex calcium matrices for surgical use in musculoskeletal infections, trauma, spine and foot/ankle.

The AlloConnex tendon and ligament portfolio supports a multitude of procedures surgeons perform to connect patients back to their active lifestyles.

The IDE Supplement allows for a reduction in the number of patients required to be enrolled in the ASPIRE IDE Study on P15-L bone graft in the lumbar spine.

The technology has shown encouraging early results for regrowth of long bone defects in patients who have lost more than six centimeters of bone.

The patents cover combinations of polymers and granular materials and further expand Kuros' patent portfolio relating to its MagnetOs product.

The transitional pass-through payment reimburses outpatient centers and ASCs for incremental cost of AUGMENT in hindfoot and ankle fusion.

The limited market release of Tempest Allograft Bone Matrix marks Spine Wave's entry into the spinal biologics market.

The companies have collaborated since 2015 to develop collagen-based bone graft products used in orthopedic and dental applications.

The product expands Aziyo's regenerative medicine portfolio and leverages proprietary processing to protect and preserve native bone cells.

Bioventus received FDA 510(k) clearance to market SIGNAFUSE® Bioactive Bone Graft in a strip format. The strips consist of 55% bioglass by weight and have been shown to induce higher levels of osteoblast differentiation compared to other synthetic bone graft strips....